• 1
    Tam CS, Heersche JNM, Murray TM, Parsons JA 1982 PTH stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110: 506512.
  • 2
    Uzawa T, Hori M, Ejiri S, Ozawa H 1995 Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone 16: 477484.
  • 3
    Hock JM, Gera I 1992 Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to PTH. J Bone Miner Res 7: 6572.
  • 4
    Kitazawa R, Imai Y, Fukase M, Fujita T 1991 Effects of continuous infusion of PTH and PTH-related peptide on rat bone in vivo: Comparative study by histomorphometry. Bone Miner 12: 157166.
  • 5
    Dobnig H, Turner RT 1997 The effects of programmed administration of human PTH fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138: 46074612.
  • 6
    Jaeger P, Jones W, Kashgarian M, Baron R, Clemens TL, Segre GV, Hayslett JP 1987 Animal model of primary hyperparathyroidism. Am J Physiol 252: E790E799.
  • 7
    Ibrahim MM, Forte LR, Thomas ML 1982 Maintenance of normocalcemia by continuous infusion of the synthetic bovine PTH (1-34) in parathyroidectomized rats. Calcif Tissue Int 34: 553557.
  • 8
    Bilezikian JP, Silverberg SJ, Gartenberg F, Kim TS, Jacobs TP, Siris ES, Shane E 1994 Clinical presentation of primary hyperparathyroidism. In: BilezikianJP, LevineMA, MarcusR (eds) The Parathyroids. Raven Press, Ltd., New York, pp. 457469
  • 9
    Diamond T, Ng ATM, Levy S, Magarey C, Smart R 1996 Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: A preliminary report. Osteoporos Int 6: 329333.
  • 10
    Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR 1996 Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 125: 360368.
  • 11
    Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15: 175192.
  • 12
    Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of PTH on bone. Endocr Rev 14: 227246.
  • 13
    Segre GV 1983 Amino terminal radioimmunoassay for human PTH. In: FrameB, PottsJTJr (eds.) Clinical Disorders of BoneMineral Metabolism. Excerpta Medica, Amsterdam, Netherls, pp. 1421.
  • 14
    Hvid I, Hansen SL 1985 Trabecular bone strength patterns at the proximal tibial epiphysis. J Orthop Res 3: 404472.
  • 15
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V 1996 Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 11: 421429.
  • 16
    Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: A tutorial. Bone 14: 595608.
  • 17
    Sogaard CC, Wronski TJ, McOsker JE, Mosekilde L 1994 The positive effect of PTH on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocrinology 134: 650657.
  • 18
    Brown JP, Malaval L, Chapuy MC, Delmas PD, Duard C, Meunier PJ 1984 Serum bone-gla protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet May: 10911093.
  • 19
    Chestnut CH, McClung MR, Ensrud KE, Bell NH, Genant HK, Harris ST, Singer FR, Stock JL, Yood RA, Delmas PD, Kheu U, Pryor-Tilloson S, Santora AC 1995 Alendronate treatment of the postmenopausal osteoporotic woman: Effects of multiple dosages on bone mass and bone remodeling. Am J Med 99: 144152.
  • 20
    Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J 1996 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81: 3743.
  • 21
    Health H III, Hodgson SF, Kennedy MA 1980 Primary hyperparathyroidism incidence, morbidity and potential economic impact in a community. N Engl J Med 302: 189193.
  • 22
    Wishart J, Horowitz M, Neer A, Nordin BEC 1990 Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism. Arch Intern Med 150: 13291331.
  • 23
    Lindsay R 1990 Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76: 290295.
  • 24
    Ettinger B, Gennant HK, Cann CE 1987 Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 106: 4045.
  • 25
    McDermott MT, Perloff JJ, Kidd GS 1994 Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res 9: 509514.
  • 26
    Selby PL, Peacock M 1986 Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med 314: 14811485.
  • 27
    Marcus R, Madvig P, Crim M, Pont A, Kosek J 1984 Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med 147: 681685.
  • 28
    Gallagher JC, Wilkinson R 1973 The effect of ethinyl estradiol on calcium and phosphorus metabolism of postmenopausal women with primary hyperparathyroidism. Clin Sci 45: 785802.
  • 29
    Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, Bilezikian JP 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80: 723728.
  • 30
    Parisien M, Mellish RWE, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW 1992 Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis. J Bone Miner Res 7: 913919.
  • 31
    Wronski TJ, Cintron M, Dann LM 1988 Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Bone 43: 179183.
  • 32
    Wronski TJ, Dann LM, Horner SL 1989 Time course of vertebral osteopenia in ovariectomized rats. Bone 10: 295301.
  • 33
    Li M, Shen Y, Wronski TJ 1997 Time course of femoral neck osteopenia in ovariectomized rats. Bone 20: 5561.
  • 34
    Shen V, Birchman R, Xu R, Otter M, Wu DD, Lindsay R, Dempster DW 1995 Effects of reciprocal treatment with estrogen and estrogen plus PTH on bone structure and strength in ovariectomized rats. J Clin Invest 96: 23312338.